Comorbidities and Costs of Adult Patients Diagnosed with Attention-Deficit Hyperactivity Disorder
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Introduction The purpose of this retrospective study was to examine the prevalence of comorbidities, resource use, direct medical costs, and the costs associated with missed work for adults diagnosed with attention-deficit hyperactivity disorder (ADHD). Study design From a large claims database that captures inpatient, outpatient and prescription drug services, individuals diagnosed with ADHD between the years 1999 and 2001 were retrospectively identified. The ADHD cohort (n = 2252) were matched with a non-ADHD cohort (n = 2252) on a 1 : 1 ratio, based upon age, gender, metropolitan statistical area and type of insurance coverage. The ADHD cohort was compared with the non-ADHD cohort for differences in comorbidities and direct medical costs (inpatient, outpatient and prescription drug costs) using year 2001 prices. Using data from six Fortune 200 employers, time missed from work and costs associated with absenteeism, short-term disability and worker's compensation was examined for a subsample (n = 354) of the employees diagnosed with ADHD. Chi-square and t-statistics were used to compare the ADHD population with the control group with regards to comorbidites and service use. Analysis of covariance and multivariate regressions were used to examine differences in days missed from work, direct medical costs and costs associated with missed work. Results Adults diagnosed with ADHD were significantly more likely to have a comorbid diagnosis of asthma (p = 0.0014), anxiety (p Concl…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Adult patients with ADHD have been shown to have higher health care resource utilization (HRU) and costs compared with those without ADHD.3,4”
From Health care resource utilization and costs associated with psychiatric comorbidities in adult patients with attention-deficit/ hyperactivity disorder (2024) · cites this paper as [4]
In the citing paper
“Despite previous studies reporting excess HRU and costs associated with ADHD,3,4,11,12 little is known about the incremental clinical and economic burden specifically attributable to psychiatric comorbidities of ADHD in adults.”
From Health care resource utilization and costs associated with psychiatric comorbidities in adult patients with attention-deficit/ hyperactivity disorder (2024) · cites this paper as [4]
In the citing paper
“The burden of ADHD has been demonstrated in prior studies evaluating the clinical and economic burden borne by adult patients with ADHD compared with their counterparts without ADHD,3-5,14,15 but few studies have evaluated the incremental burden imposed by common ADHD psychiatric comorbidities.”
From Health care resource utilization and costs associated with psychiatric comorbidities in adult patients with attention-deficit/ hyperactivity disorder (2024) · cites this paper as [4]
Citations
Cites
Barr, A. J. (1979) · Medical Entomology and Zoology · Cited by 7,198
Smearing Estimate: A Nonparametric Retransformation Method
Duan, N. (1983) · Journal of the American Statistical Association · doi:10.1080/01621459.1983.10478017 · Cited by 2,232
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.12.1792 · Cited by 950
Subcommittee on Attention-Deficit/Hyperactivity Disorder Committee on Quality Improvement (2001) · Pediatrics · doi:10.1542/peds.108.4.1033 · Cited by 878
Attention deficit hyperactivity disorder adults: Comorbidities and adaptive impairments
Murphy, K., & Barkley, R. A. (1996) · Comprehensive Psychiatry · doi:10.1016/s0010-440x(96)90022-x · Cited by 700
Goetzel, R. Z., Hawkins, K., Ozminkowski, R. J., & Wang, S. (2003) · Journal of Occupational and Environmental Medicine · doi:10.1097/00043764-200301000-00007 · Cited by 694
Attention-deficit/hyperactivity disorder in adults: an overview
Faraone, S. V., Biederman, J., Spencer, T., Wilens, T., Seidman, L. J., Mick, E., & Doyle, A. E. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00889-1 · Cited by 679
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.11.1652 · Cited by 528
WENDER, P. H., WOLF, L. E., & WASSERSTEIN, J. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb05770.x · Cited by 498
Pharmacotherapy of Attention-deficit/Hyperactivity Disorder Reduces Risk for Substance Use Disorder
Biederman, J., Wilens, T., Mick, E., Spencer, T., & Faraone, S. V. (1999) · Pediatrics · doi:10.1542/peds.104.2.e20 · Cited by 493
Research works printed but not linked: 1
- Barkley, 2001, Trends in Evidence-Based Neuropsychiatry (TEN), 3, 64
Cited by
Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan
Franke, B., Michelini, G., Asherson, P., Banaschewski, T., Bilbow, A., Buitelaar, J. K., Cormand, B., Faraone, S. V., Ginsberg, Y., Haavik, J., et al. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.08.001 · Cited by 643
Economic impact of childhood and adult attention-deficit/hyperactivity disorder in the United States
Doshi, J. A., Hodgkins, P., Kahle, J., Sikirica, V., Cangelosi, M. J., Setyawan, J., Erder, M. H., & Neumann, P. J. (2012) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2012.07.008 · Cited by 440
Attention-deficit/hyperactivity disorder and adverse health outcomes
Nigg, J. T. (2013) · Clinical Psychology Review · doi:10.1016/j.cpr.2012.11.005 · Cited by 436
Sobanski, E., Brüggemann, D., Alm, B., Kern, S., Deschner, M., Schubert, T., Philipsen, A., & Rietschel, M. (2007) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-007-0712-8 · Cited by 378
“5% respectively [32] which points to a higher prevalence of bipolar disorders in adults with ADHD than in the general population.”
Attention-Deficit/Hyperactivity Disorder and Attention Networks
Bush, G. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.120 · Cited by 358
“…of substance abuse, traffic accidents, persistent neuropsychological impairments, and the attendant increased costs to society (Biederman, 2004; Donnelly et al, 2004; Guevara et al, 2001; Secnik et al, 2005; Vos et al, 2005), determining the underlying neural substrate of ADHD is of great import.”
Background
Metadata
- Authors
- Secnik, K., Swensen, A., & Lage, M. J.
- Affiliations
- Eli Lilly (United States) (US)
- Quinnipiac University (US)
- Corresponding author
- Lage, Maureen J
- ORCID
- Lage, Maureen J
- Venue
- PharmacoEconomics
- Published
- 2005
- Volume
- 23
- Issue
- 1
- Pages
- 93-102
- ISSN
- 1170-7690 (ISSN-L)
- OpenAlex
- W2079907329
- Semantic Scholar
- 628d08113bb25d20163d6d1f7034ff994c04935e
- Cited by
- 247
- References
- 37
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 7 · 2023: 10 · 2022: 5 · 2021: 10 · 2020: 7 · 2019: 6 · 2018: 8 · 2017: 10 · 2016: 12 · 2015: 10 · 2014: 8 · 2013: 17 · 2012: 19
- FWCI
- 10.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- PharmacoEconomics (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- attention deficit hyperactivity disorder, adult ADHD, comorbidities, health care costs, resource utilization (health care), missed work, absenteeism, short-term disability, workers' compensation, asthma, depression, bipolar disorder, anxiety, substance abuse, oppositional disorder, antisocial personality disorder, economic burden, productivity loss, health care utilization, prescription drug costs, inpatient and outpatient costs
- MeSH terms
- Absenteeism, Adolescent, Adult, Aged, Attention Deficit Disorder with Hyperactivity, Female, Humans, Male, Middle Aged, Retrospective Studies, Workers' Compensation, Cohort Studies, Comorbidity, Case-Control Studies, Health Care Costs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comorbidities and Costs of Adult Patients Diagnosed with Attention-Deficit Hyperactivity Disorder. https://app.cochat.ai/papers/10.2165/00019053-200523010-00008
- The paper
- Secnik, K., Swensen, A., & Lage, M. J. (2005). Comorbidities and Costs of Adult Patients Diagnosed with Attention-Deficit Hyperactivity Disorder. PharmacoEconomics. https://doi.org/10.2165/00019053-200523010-00008
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.